Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 10, 2013

View Archived Issues

Small-molecule lipid II inhibitors identified as potential antibacterials

NDC-1308, a novel compound inducing remyelination and slowing clinical signs in EAE mice

S. pneumoniae whole-cell vaccine undergoes phase I study

Alkermes completes enrollment in pivotal study of aripiprazole lauroxil

Three clinical studies of Parkinson's disease candidate opicapone reported

WISP1 gene expression linked to adipose tissue differentiation and obesity

Gicare Pharma develops compounds for visceral pain

Novel PCSK9 expression inhibitors described in Kowa patent

U.S. researchers design prodrugs of riluzole

Mileutis divulges peptides for lactation disorders

Sysmex Inostics and Bayer HealthCare to develop blood-based companion diagnostic tests

Molecular Templates raises funds to advance MT-3724

The Medicines Company and Alnylam to advance ALN-PCSsc

Ariad Pharmaceuticals gives update on Iclusig development

Immunogenicity and efficacy of HIVAX vaccine: results of a first-in-human study

CGEN-15001 is effective in an animal model of type 1 diabetes

FDA accepts filing for Bunavail NDA

Promedior begins phase II study of PRM-151 in myelofibrosis

Phase I/II study of Portola Pharmaceuticals' dual SYK/JAK inhibitor commences

QRxPharma meets with the FDA regarding MoxDuo NDA

Novogen acquires new technology targeting the Tm5NM1 protein

Phase III bivalirudin trial enrolls first patient

Kowa seeks approval in Japan for K-115

Morphotek reports initiation of phase I study of MORAb-004 in pediatric patients

Positive risk-benefit leads Gilead to end phase III study of idelalisib early

Nycomed to return worldwide rights to veltuzumab

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.